Clinical Trials Registry — What, When and Why?

Clinical trials have the initial purpose to guarantee that new pharmaceuticals and other medical products are not only being adequately tested but they are safe to use and efficient. Taking medicaments should not put humans and their lives in danger. Therefore, ensuring that trial participants and consumers are protected and their rights are taken into consideration become priorities for researchers. The other aim of clinical trials is to produce outcomes which are beneficial not only to patients but to the Pharmaceutical and Clinical sector too.

Prior to any clinical trial start, there is a need of clinical study registry. To present it differently, any research project should be registered. But what is the purpose of registering clinical studies? Why is the registry needed?

To begin with, registering clinical trials is pivotal because it minimizes the possibility of duplications in research efforts. This is to suggest that when one organization have plans to carry out a specific research, other organizations will be informed and can find out about it. In consequence this will save time, efforts and money and will enable other institutions to refocus and choose to invest on another medical product.

After that, rregistering studies at the very beginning help researchers achieve timely, well-structured and accurate updates when they are supposed to. In other words, clinical trials registry minimizes the disadvantageous occurrences and circumstances of selective reporting of the trial advancement and trial outcomes. What is more, it also eliminates the risks of data violation and makes the whole process more bias-free.

To continue with, these trial registries are extremely useful to patients, especially in situations when they want to check how and where exactly the research is going. The general public can also take advantage of this. Precisely how? The answer is simple. The audience can find out more about the trial itself, along with its purpose, expected results and more.

In addition to this, clinical studies depend on resources which are distributed by someone else, not directly involved and being part of the research team or organization. Trial registries, then, promote better allocation of resources (funds) from third parties.

Finally, ethical and institutional review boards (IRBs) are given the opportunity to determine how appropriate a clinical trial is much faster. Furthermore, they can also review the similarities between different studies and can check how relevant the product is.